Effect of anagliptin on lipid metabolism in non-diabetic men

Effect of anagliptin on lipid metabolism in non-diabetic men - Effect of anagliptin on lipid metabolism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011355

Enrollment

Registered

2013-08-04

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

anagliptin (200mg) for 14 days

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: non-diabetic men

Exclusion criteria

Exclusion criteria: diabetes

Design outcomes

Primary

Measure	Time frame
LDL-C, HDL-C, LDL-C, TG, cholesterol absorption, cholesterol synthesis	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026